Trigeminal Neuralgia (Tn) Therapeutics Market - Global Industry Analysis and Forecast 2015 - 2021

Trigeminal Neuralgia (TN) Therapeutics Market - Global Industry

Analysis and Forecast 2015 - 2021

Persistence Market Research

Trigeminal Neuralgia (TN) Therapeutics

Market - Global Industry Analysis and

Forecast 2015 - 2021

Persistence Market Research

1

Trigeminal Neuralgia (TN) Therapeutics Market - Global Industry

Analysis and Forecast 2015 - 2021

Persistence Market Research Released New Market Report on “Trigeminal Neuralgia (TN)

Therapeutics Market - Global Industry Analysis and Forecast 2015 - 2021”.

Trigeminal neuralgia occurs when the functioning of the trigeminal nerve is disrupted due to damage of

the nerve. Trigeminal neuralgia is a chronic condition resulting in intense and extreme pain in the face and

is more common among females. The incident represents electrical shock-like feeling and lasts from few

seconds to minutes. The etiology of trigeminal neuralgia includes compression of blood vessels,

degeneration of arteries, myelin sheath infiltration and idiopathic. Trigeminal neuralgia is most commonly

seen after the age of 40 years. Diagnosis of trigeminal neuralgia includes dental pathology diagnosis,

temporal arteritis’ diagnosis, disorders of myelin diagnosis, tumor in posterior fossa diagnosis and

migraine diagnosis. Treatment for trigeminal neuralgia includes anticonvulsants or painkiller drug and

surgery. There are various types of surgical procedures available for trigeminal neuralgia such as

rhizotomy, stereotactic radiosurgery, microvascular decompression, transcutaneous electrical nerve

stimulation and acupuncture.

Request Full TOC: http://www.persistencemarketresearch.com/toc/5759

With the rising geriatric population the market for trigeminal neuralgia therapeutics is experiencing a

significant growth worldwide as geriatrics are more prone to get this disease. Moreover, technological

advancements in diagnostic tests and growing public awareness about the disease also drives the growth

of trigeminal neuralgia therapeutics market...